Allogene Therapeutics Growth Metrics (2019-2025) | ALLO

Growth Metrics Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -21.86M3.28M-15.78M-36.25M-10.12M-22.18M4.09M-3.91M2.46M34.19M47.58M33.51M-5.34M
EBITDA Margin Growth (3y) -29.52M22.50M7.43M25.84M14.80M32.95M
EBITDA Margin (QoQ) -16.17M0.21M15.97M-21.87M8.98M-18.86M-4.50M4.26M-3.08M7.41M-12.50M10.62M0.89M-3.46M-2.07M-0.71M
EBIT Margin Growth (1y) -20.51M4.17M-14.71M-37.08M-12.51M-24.64M1.93M-3.45M1.44M35.81M48.00M35.94M-5.87M
EBIT Margin Growth (3y) -31.58M23.03M7.47M24.86M14.09M31.86M
EBIT Margin (QoQ) -16.13M0.29M15.85M-20.52M8.55M-18.59M-6.52M4.04M-3.58M7.97M-11.89M8.94M0.29M-3.12M-2.23M-0.81M
EBT Margin Growth (1y) -20.38M4.10M-14.42M-36.01M-11.95M-22.97M4.37M-1.53M3.22M32.33M44.65M33.11M-5.32M
EBT Margin Growth (3y) -29.11M22.29M7.10M24.38M13.82M31.39M
EBT Margin (QoQ) -16.02M0.26M15.77M-20.39M8.47M-18.27M-5.83M3.67M-2.55M9.08M-11.73M8.42M0.59M-3.12M-2.09M-0.70M
Enterprise Value Growth (1y) -24.60%43.74%22.49%43.52%120.40%-30.35%-9.82%-55.89%-80.04%-63.06%-68.43%-76.65%-71.51%-79.69%-93.42%-76.53%52.92%-119.99%346.25%68.50%-89.98%44.23%-92.20%
Enterprise Value Growth (3y) -30.77%-28.22%-29.62%-47.12%-49.95%-62.61%-73.44%-71.09%-55.69%-26.31%-54.74%-54.80%-64.79%-26.47%-71.60%
Enterprise Value Growth (5y) -32.08%-15.04%-36.60%-43.33%-54.64%-14.94%-63.45%
Enterprise Value (QoQ) 20.79%-7.40%-8.15%-26.60%130.26%-21.10%7.62%12.72%-27.24%2.16%-47.36%-48.99%34.66%-12.70%-61.06%-37.76%-4.01%-71.71%38.86%305.57%-112.55%731.61%-47.57%-75.89%-169.84%188.38%
FCF Margin Growth (1y) -17.97M4.56M-7.07M-24.53M-4.57M-21.39M-7.51M-1.13M-2.85M29.70M30.22M28.95M-3.59M
FCF Margin Growth (3y) -25.40M15.11M4.57M21.52M8.32M18.60M
FCF Margin (QoQ) -11.40M0.76M10.65M-17.98M11.12M-10.87M-6.80M1.98M-5.69M3.00M-0.41M0.25M0.11M-1.03M-2.07M-0.59M
Interest Coverage Ratio Growth (1y) 81.81%
Interest Coverage Ratio (QoQ) -4.05%41.80%51.22%38.43%
Net Margin Growth (1y) -20.38M4.10M-14.42M-36.01M-11.95M-22.97M4.37M-1.53M3.22M32.33M44.65M33.11M-5.32M
Net Margin Growth (3y) -29.11M22.29M7.10M24.38M13.82M31.39M
Net Margin (QoQ) -16.02M0.26M15.77M-20.39M8.47M-18.27M-5.83M3.67M-2.55M9.08M-11.73M8.42M0.59M-3.12M-2.09M-0.70M
Operating Margin Growth (1y) -20.51M4.17M-14.71M-37.08M-12.51M-24.64M1.93M-3.45M1.44M35.81M48.00M35.94M-5.87M
Operating Margin Growth (3y) -31.58M23.03M7.47M24.86M14.09M31.86M
Operating Margin (QoQ) -16.13M0.29M15.85M-20.52M8.55M-18.59M-6.52M4.04M-3.58M7.97M-11.89M8.94M0.29M-3.12M-2.23M-0.81M
Return on Assets Growth (1y) 6.0010.003.00-3.004.00-3.00-3.00-3.00-22.00-22.00-22.00-18.00-7.00-1.003.00-1.001.00-2.00-5.00-2.00
Return on Assets Growth (3y) -12.00-15.00-22.00-24.00-25.00-26.00-22.00-22.00-28.00-25.00-24.00-21.00
Return on Assets Growth (5y) -18.00-18.00-24.00-26.00
Return on Assets (QoQ) -3.006.004.00-1.001.00-2.00-2.006.00-5.00-2.00-2.00-13.00-6.00-1.002.00-2.001.002.00-1.000.00M-3.00-1.002.00
Return on Capital Employed Growth (1y) 7.0013.004.00-3.005.00-3.00-3.00-3.00-24.00-26.00-26.00-21.00-9.00-2.001.00-3.000.00M-3.00-6.00-3.00
Return on Capital Employed Growth (3y) -12.00-16.00-25.00-27.00-28.00-31.00-28.00-27.00-34.00-31.00-30.00-27.00
Return on Capital Employed Growth (5y) -21.00-21.00-30.00-32.00
Return on Capital Employed (QoQ) -3.007.004.00-2.002.00-1.00-2.006.00-5.00-2.00-2.00-15.00-7.00-2.003.00-3.000.00M1.00-1.000.00M-3.00-2.002.00
Return on Equity Growth (1y) 7.0012.003.00-4.004.00-4.00-5.00-5.00-28.00-30.00-30.00-24.00-10.00-1.003.00-2.00-1.00-5.00-9.00-7.00
Return on Equity Growth (3y) -17.00-22.00-32.00-33.00-34.00-35.00-32.00-31.00-38.00-36.00-36.00-33.00
Return on Equity Growth (5y) -28.00-28.00-38.00-42.00
Return on Equity (QoQ) -4.008.004.00-1.001.00-1.00-2.006.00-6.00-2.00-3.00-17.00-8.00-2.004.00-3.000.00M2.00-2.00-1.00-4.00-2.000.00M
Return on Sales Growth (3y) 0.08M0.04M0.03M
Return on Sales (QoQ) -140.00-8.00-6.00-0.04M-0.01M